# FULVESTRANT
> **ANDA211730** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2021-06-11
## Drug
- **FDA Application Number:** ANDA211730
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FULVESTRANT
- **Generic name:** Fulvestrant
- **Active ingredients:** FULVESTRANT
- **Dosage form:** SOLUTION
- **Route:** INTRAMUSCULAR
- **Marketing status:** Discontinued
- **Sponsor:** APOTEX
- **First approval:** 2021-06-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211730)
---
*MORVS · CC0 1.0*